...
首页> 外文期刊>British Journal of Radiology >Protein C and/or S deficiency presenting as peripheral arterial insufficiency.
【24h】

Protein C and/or S deficiency presenting as peripheral arterial insufficiency.

机译:蛋白C和/或S缺乏症表现为周围动脉供血不足。

获取原文
获取原文并翻译 | 示例
           

摘要

Although protein C and/or S deficiency has frequently been associated with venous thromboembolic events, instances of arterial thromboses have been reported. However, the exact incidence of protein C and/or S deficiency in patients with peripheral arterial insufficiency has not been established. Furthermore, given the lack of adequate studies to define the natural history and angiographic findings of these patients, the treatment has not been well delineated. Therefore, we conducted a prospective study to investigate the prevalence, characteristic angiographic findings and optimal treatments in patients with peripheral arterial insufficiency associated with protein C and/or S deficiency. Between September 2000 and August 2004, 133 patients who presented with peripheral arterial insufficiency underwent hypercoagulability tests before the initiation of any treatments. Of these, 11 patients (8.3%) with protein C and/or S deficiency were included in this study. There were nine males and two females. The ages ranged from 38 years to 72 years (mean 57 years). All patients showed characteristic angiographic findings: long segment thrombotic occlusion of a main peripheral artery without evidence of atherosclerosis or with mild atherosclerotic changes in the aorta and other major arterial trees. Surgical or endovascular procedures were performed in nine patients: bypass graft in four, thrombectomy in four and catheter-directed thrombolysis in one. Conservative treatment with full anticoagulation was performed in two patients. All patients received pre- and post-operative anticoagulation. Except for one amputated case, clinical and vascular laboratory improvements were achieved in 10 patients. Mean follow-up period was 21 months (range 4-45 months). However, one patient, in whom re-vascularization surgery was performed successfully, discontinued warfarin therapy himself at 10 months after surgery, graft occlusion and limb loss occurred at 30 months after surgery. This initial experience suggests that protein C and/or S deficiency may be an independent risk factor for peripheral arterial insufficiency. Patients who present with peripheral arterial insufficiency and protein C and/or S deficiency demonstrate characteristic angiographic findings. Once the diagnosis of protein C and/or S deficiency is made, patients should be treated with life-long anticoagulation.
机译:尽管蛋白C和/或S缺乏症经常与静脉血栓栓塞事件有关,但已报道了动脉血栓形成的情况。然而,尚未确定患有外周动脉供血不足的患者中蛋白质C和/或S缺乏症的确切发病率。此外,由于缺乏足够的研究来定义这些患者的自然病史和血管造影结果,因此尚未很好地描述治疗方法。因此,我们进行了一项前瞻性研究,以调查与蛋白C和/或S缺乏症相关的外周动脉供血不足的患者的患病率,特征性血管造影结果和最佳治疗方法。在2000年9月至2004年8月之间,有133位表现为外周动脉供血不足的患者在开始任何治疗之前接受了高凝试验。在这些研究中,有11位(8.3%)蛋白C和/或S缺乏症患者被纳入研究。男9例,女2例。年龄从38岁到72岁(平均57岁)不等。所有患者均表现出特征性的血管造影检查结果:主要外周动脉长段血栓闭塞,无动脉粥样硬化或主动脉及其他主要动脉树轻度动脉粥样硬化改变的迹象。 9例患者接受了外科手术或血管内手术:4例行旁路移植术,4例行血栓切除术,1例行导管定向溶栓术。两名患者进行了全面抗凝的保守治疗。所有患者在术前和术后均接受抗凝治疗。除一例截肢病例外,另有10例患者的临床和血管实验室改善。平均随访期为21个月(范围4-45个月)。但是,其中一名成功进行了血管再通手术的患者在手术后10个月停止了华法林治疗,在手术后30个月发生了移植物阻塞和肢体脱落。最初的经验表明,蛋白C和/或S缺乏可能是外周动脉供血不足的独立危险因素。表现为外周动脉供血不足和蛋白C和/或S缺乏的患者表现出特征性血管造影结果。一旦诊断出蛋白C和/或S缺乏症,就应使用终身抗凝治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号